Key points are not available for this paper at this time.
It is assumed that a chronic disease progresses from a pre-clinical state to a clinical state. If an individual, having pre-clinical disease, participates in an early detection programme, the disease may be detected in the pre-clinical state. The potential benefit of a screening programme is related to the lead time gained by early diagnosis. A stochastic model is developed for early detection programmes which leads to an estimate of the mean lead time as a function of observable variables. An investigation is also made of a non-progressive disease model in which individuals in a pre-clinical state may not necessarily advance to the clinical state.
Building similarity graph...
Analyzing shared references across papers
Loading...
Marvin Zelen
Harvard University
M Feinleib
University of Hawaiʻi at Mānoa
Biometrika
National Institutes of Health
University at Buffalo, State University of New York
Building similarity graph...
Analyzing shared references across papers
Loading...
Zelen et al. (Wed,) studied this question.
synapsesocial.com/papers/6a0e356f1d0a44496ac8343a — DOI: https://doi.org/10.1093/biomet/56.3.601